Ominous signaling for Dynavax (DVAX) at Stocktwits

DVAX defenders gonna defend; but against what? I touched a few nerves with my insulting comment about DVAX as it gets walloped, post-earnings (in which revenue soared but so did cost of revenue, prompting me to take a minor partial profit in AH yesterday due to my concern about said cost ramp). But it’s up to individuals to decide whom I was or was not … Continue reading Ominous signaling for Dynavax (DVAX) at Stocktwits

DVAX: Want to see volatility?

Dynavax stock drops, pops with massive volatility Well, not all news out of China is bad this week. Since the last post on the subject my DVAX story saw a massive drop (on bad COVID related news, which I held without a thought of selling) and today, on positive COVID Adjuvant news a massive pop after release of trial results from China’s Clover Biopharma (with … Continue reading DVAX: Want to see volatility?

tyx

What’s a Hype-o-Phobe to do in the Age of COVID?

Dynavax explodes on COVID news, but that’s not why I hold it What’s a sensible market manager supposed to do when he keeps buying a stock for its commercialization of a Hepatitis vaccine but said stock keeps getting caught up in COVID hype? Why, in this case take another profit but only on a partial position and hold the rest. Yeah, that sounds about right. … Continue reading What’s a Hype-o-Phobe to do in the Age of COVID?

dvax

DVAX Position Halved as Casino Patrons Take Over

I’ve already taken one partial profit on what was supposed to be a long-term hold for the commercialization of its Hepatitis vaccine. But then the remaining position grew too large again, especially considering that my boring long-term vaccine investment has gotten all caught up with some seedy characters. “Coronavirus Vaccine stock”? Really? Some automated TA outfit is guiding casino patrons on this Coronavirus stock. I … Continue reading DVAX Position Halved as Casino Patrons Take Over

A Big “Eff You” to Whoever Drove DVAX Down Into the News

It’s so typical and it’s no wonder that the insider stock operators who run the markets (market makers and other Wall Street wink winking, nudge nudging types) have such a greasy reputation among we, the lumpen investoriate. Here is the news I was waiting for as I watched them croak the stock yesterday. Now, I am no expert in BioPharma, but it appears that the … Continue reading A Big “Eff You” to Whoever Drove DVAX Down Into the News

A Baby Intuitive Surgical Rams Upward

Mazor Robotics (MZOR) is in partnership with one of my other Medical Device/Equipment holdings, Medtronic (MDT) and that is not to be taken lightly. It legitimized Mazor’s status within the Medical Robot ‘me too’ movement. Last week I noted that I’d held DVAX (a biotech company) despite a stupid breakdown (MMs will come out to play, after all) into earnings and was rewarded nicely for … Continue reading A Baby Intuitive Surgical Rams Upward

DVAX Hangs in By a Hair, Bursts Upward

I had held this one for two reasons… Its fundamental potential and… Its chart. And then there was only one reason I kept holding after the daily chart got busted. I had resisted taking a significant profit in April and got repaid with a subsequent paper loss. It was the old ‘that’s show biz’ thing and it comes with the territory if you’re not a … Continue reading DVAX Hangs in By a Hair, Bursts Upward

nftrh plus

NFTRH+; Update on Feb. 28 Biotech Stock Highlight

DVAX was originally highlighted for its interesting chart setup (we linked some info on the company’s fundamental situation as well) and today I’d like to update the chart, which is no longer in a setup, but nearing a breakout above resistance with good looking lower panel indicators across the board. The original update did not have a target except to note that if successful, we’d … Continue reading NFTRH+; Update on Feb. 28 Biotech Stock Highlight